Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iofolastat I 123 is a diagnostic agent under investigation in clinical trial NCT00992745 (A Phase I Pilot Study in Subjects With Metastatic Prostate Cancer).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Iofolastat I 123 is a diagnostic agent under investigation in clinical trial NCT00992745 (A Phase I Pilot Study in Subjects With Metastatic Prostate Cancer). |
Synonyms | MIP 1072, MIP1072, Iofolastat (123-I), (123)I-MIP-1072, MIP-1072 |
Molecular Weight | 531.33 |
Formula | C19H26IN3O7 |
CAS No. | 949575-24-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iofolastat I 123 949575-24-0 (123)I-MIP 1072 MIP 1072 MIP1072 Iofolastat (123-I) 123-I (123)I-MIP-1072 Iofolastat I123 (123)I-MIP1072 Iofolastat I-123 Iofolastat MIP-1072 inhibitor inhibit